Elaine Chen, Adam Feuerstein, and Allison DeAngelis

BioTech

Biotech’s next gold rush, GLP-1 shortages, and STAT Summit highlights

Why are biotech investors so interested in autoimmune disease? Who is behind the telehealth GLP-1 boom? And what were our favorite moments from the STAT

Elaine Chen, Adam Feuerstein, and Allison DeAngelis October 17, 2024

BioTech

UnitedHealth’s doctor empire, an FDA departure, and Viking’s obesity moves

What makes UnitedHealth similar to Standard Oil? Is Viking Therapeutics an attractive acquisition target? And is Adam good at math? We discuss all that and

Elaine Chen, Adam Feuerstein, and Allison DeAngelis July 25, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.

Elaine Chen, Adam Feuerstein, and Allison DeAngelis

Biotech’s next gold rush, GLP-1 shortages, and STAT Summit highlights

UnitedHealth’s doctor empire, an FDA departure, and Viking’s obesity moves

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

Subscribe